Amount$143M
SeriesSeries B
AnnouncedMay 27, 2020
Time since last round727 mo
SectorHealthcare, Drug Discovery, Drug Development, DNA, Next Generation Sequencing
Sub-sectorMachine Learning
Mixed
A mixed round — some signals are off the norm.
Round size vs peers
Far above the typical Series B round (5.1× the median) — an outlier.
Syndicate size
8 investors on the cap table.
Insider conviction
7 existing investors re-upped — insiders doubling down.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series B rounds (996)
Round size distribution94th pct
smaller Series B roundslarger
